Trial Profile

A Phase 1 Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869) (Abbott Laboratories M11-306).

Status: Active, no longer recruiting

Phase of Trial: Phase I

Latest Information Update: 31 Jul 2011

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Linifanib (Primary) ; Ketoconazole
Indications Cancer
Focus Pharmacokinetics

Most Recent Events

17 Mar 2011 Planned End Date changed from 1 Oct 2012 to 1 Oct 2011 as reported by ClinicalTrials.gov.
17 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
04 May 2010 Actual initiation date (Apr 2010), planned patient no [12], trial investigator [McKee MD] added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com